{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:37:24Z","timestamp":1783593444518,"version":"3.55.0"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10,1]]},"abstract":"<jats:p>OBJECTIVE. Child neurologists and neonatologists often discharge newborn infants with phenobarbital treatment for weeks to months despite the absence of continuing seizure activity. We conducted a national survey to determine the degree of variation in this practice.<\/jats:p><jats:p>METHODS. Surveys were sent to a randomly generated list of board-certified child neurologists (N = 609) and neonatologists (N = 579). The survey consisted of 3 parts, that is, questions related to overall attitudes and practices, specific patient scenarios, and respondent demographic characteristics. Responses were tabulated and analyzed for all respondents combined and for child neurologists and neonatologists separately. Variation in practices between respondents and the consistency between the respondents' stated use of phenobarbital in practice and their answers to various clinical scenarios were evaluated.<\/jats:p><jats:p>RESULTS. Responses were received from 118 child neurologists (20.7%) and 125 neonatologists (23.1%). There was wide variation in practices, with little difference in the response frequencies between child neurologists and neonatologists. Physicians were more likely to respond yes to continuation of phenobarbital treatment in a given clinical situation than would be predicted on the basis of their answers regarding overall frequency of use.<\/jats:p><jats:p>CONCLUSIONS. Since the survey of practices 15 years ago, child neurologists and neonatologists are reporting less frequent and shorter phenobarbital treatment after resolution of neonatal seizures, although there remains considerable variation in practices. Moreover, what physicians report as their practice in general is inconsistent with how they respond to specific clinical cases of neonatal seizures.<\/jats:p>","DOI":"10.1542\/peds.2007-3278","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T13:29:28Z","timestamp":1222867768000},"page":"731-735","source":"Crossref","is-referenced-by-count":38,"title":["Prophylactic Phenobarbital Administration After Resolution of Neonatal Seizures: Survey of Current Practice"],"prefix":"10.1542","volume":"122","author":[{"given":"Ronnie","family":"Guillet","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Neonatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Child Neurology, Golisano Children's Hospital at Strong, University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,10,1]]},"reference":[{"key":"2021120902322275400_R1","doi-asserted-by":"crossref","unstructured":"Rennie JM, Boylan GB. Neonatal seizures and their treatment. Curr Opin Neurol.\u20082003;16(2):177\u2013181","DOI":"10.1097\/00019052-200304000-00010"},{"key":"2021120902322275400_R2","doi-asserted-by":"crossref","unstructured":"Rennie JM. Neonatal seizures. Eur J Pediatr.\u20081997;156(2):83\u201387","DOI":"10.1007\/s004310050559"},{"key":"2021120902322275400_R3","doi-asserted-by":"crossref","unstructured":"Scher MS, Aso K, Beggarly ME, Hamid MY, Steppe DA, Painter MJ. Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics.\u20081993;91(1):128\u2013134","DOI":"10.1542\/peds.91.1.128"},{"key":"2021120902322275400_R4","doi-asserted-by":"crossref","unstructured":"Boer HR, Gal P. Neonatal seizures: a survey of current practice. Clin Pediatr (Phila).\u20081982;21(8):453\u2013457","DOI":"10.1177\/000992288202100801"},{"key":"2021120902322275400_R5","unstructured":"Massingale TW, Buttross S. Survey of treatment practices for neonatal seizures. J Perinatol.\u20081993;13(2):107\u2013110"},{"key":"2021120902322275400_R6","doi-asserted-by":"crossref","unstructured":"Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. CJEM.\u20082006;8(1):19\u201320","DOI":"10.1017\/S1481803500013336"},{"key":"2021120902322275400_R7","doi-asserted-by":"crossref","unstructured":"Diaz J, Schain RJ. Phenobarbital: effects of long-term administration on behavior and brain of artificially reared rats. Science.\u20081978;199(4324):90\u201391","DOI":"10.1126\/science.199.4324.90"},{"key":"2021120902322275400_R8","doi-asserted-by":"crossref","unstructured":"Holden KR, Mellits ED, Freeman JM. Neonatal seizures, part I: correlation of prenatal and perinatal events with outcomes. Pediatrics.\u20081982;70(2):165\u2013176","DOI":"10.1542\/peds.70.2.165"},{"key":"2021120902322275400_R9","doi-asserted-by":"crossref","unstructured":"Gal P. Anticonvulsant therapy after neonatal seizures: how long should it be continued? Part I: a case for early discontinuation of anticonvulsants. Pharmacotherapy.\u20081985;5(5):268\u2013273","DOI":"10.1002\/j.1875-9114.1985.tb03425.x"},{"key":"2021120902322275400_R10","doi-asserted-by":"crossref","unstructured":"Clancy RR, Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia.\u20081991;32(1):69\u201376","DOI":"10.1111\/j.1528-1157.1991.tb05614.x"},{"key":"2021120902322275400_R11","doi-asserted-by":"crossref","unstructured":"Guillet R, Kwon J. Seizure recurrence and developmental disabilities after neonatal seizures: outcomes are unrelated to use of phenobarbital prophylaxis. J Child Neurol.\u20082007;22(4):389\u2013395","DOI":"10.1177\/0883073807301917"},{"key":"2021120902322275400_R12","doi-asserted-by":"crossref","unstructured":"Ellison PH, Largent JA, Bahr JP. A scoring system to predict outcome following neonatal seizures. J Pediatr.\u20081981;99(3):455\u2013459","DOI":"10.1016\/S0022-3476(81)80348-4"},{"key":"2021120902322275400_R13","doi-asserted-by":"crossref","unstructured":"Scarpa P, Chierici R, Tamisari L, Fortini C, Volpato S. Criteria for discontinuing neonatal seizure therapy: a long-term appraisal. Brain Dev.\u20081983;5(6):541\u2013548","DOI":"10.1016\/S0387-7604(83)80057-6"},{"key":"2021120902322275400_R14","doi-asserted-by":"crossref","unstructured":"Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence. N Engl J Med.\u20081990;322(6):364\u2013369","DOI":"10.1056\/NEJM199002083220604"},{"key":"2021120902322275400_R15","doi-asserted-by":"crossref","unstructured":"Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila).\u20081999;38(7):387\u2013394","DOI":"10.1177\/000992289903800702"},{"key":"2021120902322275400_R16","doi-asserted-by":"crossref","unstructured":"Cull WL, O'Connor KG, Sharp S, Tang SF. Response rates and response bias for 50 surveys of pediatricians. Health Serv Res.\u20082005;40(1):213\u2013226","DOI":"10.1111\/j.1475-6773.2005.00350.x"},{"key":"2021120902322275400_R17","doi-asserted-by":"crossref","unstructured":"Haut SR, Veliskova J, Moshe SL. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol.\u20082004;3(10):608\u2013617","DOI":"10.1016\/S1474-4422(04)00881-6"},{"key":"2021120902322275400_R18","doi-asserted-by":"crossref","unstructured":"McCabe BK, Silveira DC, Cilio MR, et al. Reduced neurogenesis after neonatal seizures. J Neurosci.\u20082001;21(6):2094\u20132103","DOI":"10.1523\/JNEUROSCI.21-06-02094.2001"},{"key":"2021120902322275400_R19","doi-asserted-by":"crossref","unstructured":"Holmes GL, Ben-Ari Y. Seizures in the developing brain: perhaps not so benign after all. Neuron.\u20081998;21(6):1231\u20131234","DOI":"10.1016\/S0896-6273(00)80642-X"},{"key":"2021120902322275400_R20","doi-asserted-by":"crossref","unstructured":"Holmes GL, Gairsa JL, Chevassus-Au-Louis N, Ben-Ari Y. Consequences of neonatal seizures in the rat: morphological and behavioral effects. Ann Neurol.\u20081998;44(6):845\u2013857","DOI":"10.1002\/ana.410440602"},{"key":"2021120902322275400_R21","doi-asserted-by":"crossref","unstructured":"van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BC. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol.\u20081991;164(1):121\u2013128","DOI":"10.1016\/0002-9378(91)90640-D"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/4\/731\/1123179\/zpe01008000731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/4\/731\/1123179\/zpe01008000731.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:01:54Z","timestamp":1684562514000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/122\/4\/731\/71317\/Prophylactic-Phenobarbital-Administration-After"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,10,1]]},"published-print":{"date-parts":[[2008,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-3278","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}